NCT06905652View on ClinicalTrials.gov

Comparative Acute Effects of R-MDMA and S-MDMA in Healthy Participants

PHASE1RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 29, 2025

Primary Completion Date

November 30, 2026

Study Completion Date

November 30, 2026

Conditions
Healthy
Interventions
DRUG

R-3,4-methylenedioxymethamphetamine

A dose of 300mg enantiomeric R-MDMA will be administered.

DRUG

S-3,4-methylenedioxymethamphetamine

A dose of 100mg enantiomeric S-MDMA will be administered.

OTHER

Placebo

Placebo (Mannitol)

Trial Locations (1)

4031

RECRUITING

University Hospital Basel, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER